폐렴 치료제 시장 : 제품별, 감염증별, 투여 경로별, 최종 용도별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Pneumonia Therapeutics market size was valued at US$ 2,780.1 Million in 2025, expanding at a CAGR of 9.9% from 2026 to 2033.

Pneumonia Therapeutics refers to the medicines and therapeutic approaches used in treating pneumonia. The treatments involve the use of medicines to treat, prevent, and cure the illness. The treatment of pneumonia usually uses antibiotics such as macrolides, quinolones, or broad-spectrum beta-lactams for cases of bacterial pneumonia; antivirals for cases of viral pneumonia; and supportive medications such as oxygen therapies, bronchodilators, corticosteroids, and intravenous fluids. The administration of pneumonia therapeutics can be through the oral route, intravenously, and through inhalation, and this depends on many factors, including the degree of the disease, the nature of the infection, the age of the individual, and the condition of the patient. This makes pneumonia therapeutics one of the most important parts in any setting where there is a disease, including the hospital and intensive care unit settings.

Pneumonia Therapeutics Market- Market Dynamics

Increasing Prevalence Of Pneumonia To Drive Market Growth

The increasing prevalence of pneumonia is driving the demand for effective pneumonia therapeutics, because as more and more patients come up with the disease, there will be the need for appropriate treatment and management. For example, in February 2026, it was revealed by Asthma + Lung UK Org that emergency admission of patients suffering from pneumonia in hospitals in England alone grew to 579,475 as compared to 461,995 cases, representing an increase of 25.4% in two years. There were 567,760 cases of pneumonia. This rising disease burden is expected to increase demand for effective pneumonia therapeutics and treatment options.

Pneumonia Therapeutics Market- Segmentation Analysis:

The Global Pneumonia Therapeutics market is segmented on the basis of Product, Infection, Route of Administration, End Use, and Region.

Drugs play an important part in the therapeutics market of pneumonia due to their efficiency in treating bacteria, fungal, and viral infections, given that there are a lot of drugs available for the treatment of pneumonia ranging from mild to severe pneumonia. The market includes a range of drugs, such as antibiotics, antivirals, and antifungals, among others, that are employed in the treatment of pneumonia and help prevent complications due to pneumonia infections. In July 2025, Sanofi acquired Vicebio and two vaccines from it, namely VXB-241, which is a bivalent vaccine for RSV and hMPV, and VXB-251, which is a preclinical tripartite vaccine for the two viruses. The two viruses cause lower respiratory tract infections, including pneumonia. These developments are expected to support drug adoption for preventing and treating pneumonia-related respiratory infections.

The Community-acquired pneumonia (CAP) is the key segment in the Pneumonia Therapeutics market since there are a number of incidences of pneumonia in the community and there is a need to develop effective antibiotics and other treatments for the management of the disease in the patients. In July 2026, F. Hoffmann-La Roche Ltd. introduced zosurabalpin, which is an innovative antibiotic for the treatment of severe pneumonia caused by drug-resistant Gram-negative bacteria. The company stated that pneumonia is one of the serious infections that can be managed using the antibiotic drug. These developments will drive the demand for new therapies to treat severe cases of community-acquired pneumonia.

Pneumonia Therapeutics Market- Geographical Insights

The Pneumonia Therapeutics market in North America is backed up by some of the key advancements in diagnostic technologies and treatments. For example, in September 2026, per the U.S. Food and Drug Administration (gov), there are more than 1,600 FDA-cleared medical devices in use as of September 2026 in the U.S. that utilize artificial intelligence design in order to enhance diagnostics through early detection and medical diagnosis of diseases, personalized health care diagnostics and decisions, and treatments. FDA gives an example of using such technology through the application of AI-based imaging tools for detecting skin cancer, pap smear and eye images for detecting diabetes retinopathy, and a deep learning software to improve the quality of the picture. The use of such devices would drive innovations in AI-based diagnostic technologies in the U.S. healthcare industry.

Pneumonia Therapeutics Market- Competitive Landscape:

The competitive landscape is characterized by key competitors' focus on product development, strategic acquisitions, and geographical expansion. The main players in this industry are Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., and Merck & Co., Inc. Some of the strategies followed by the main companies in the industry include business development and geographic expansion. For instance, in March 2025, Merck announced that its pneumococcal 21-valent conjugate vaccine, CAPVAXIVE(R), has received approval from the European Commission to prevent invasive pneumococcal disease and pneumococcal pneumonia in adults age 18 years and older. Such strategies are helping in improving the product portfolio of key market participants.

Recent Developments:

In January 2025, Roche advanced zosurabalpin, an investigational antibody that works on Gram-negative bacteria, which are the cause of various infections, such as pneumonia, to late-stage clinical development in order to develop a novel therapeutic option for drug-resistant bacterial infections.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PNEUMONIA THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Pfizer Inc.
• Merck & Co., Inc.
• AstraZeneca PLC
• GlaxoSmithKline plc (GSK)
• Sanofi S.A.
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Lupin Limited
• Aurobindo Pharma Limited
• Baxter International Inc.
• Mylan N.V.
• Cipla Limited
• Abbott Laboratories
• Others

GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

• Drugs
• Oxygen Therapy
• Vaccine

GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY INFECTION- MARKET ANALYSIS, 2020 - 2033

• Hospital-acquired Pneumonia (HAP)
• Community-acquired Pneumonia (CAP)
• Ventilator-associated Pneumonia (VAP)

GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033

• Oral
• Parenteral
• Others

GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

• Hospitals
• Specialty Clinics
• Homecare
• Others

GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Pneumonia Therapeutics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Pneumonia Therapeutics Market Snippet by Product
  • 2.1.2. Pneumonia Therapeutics Market Snippet by Infection
  • 2.1.3. Pneumonia Therapeutics Market Snippet by Route of Administration
  • 2.1.4. Pneumonia Therapeutics Market Snippet by End Use
  • 2.1.5. Pneumonia Therapeutics Market Snippet by Country
  • 2.1.6. Pneumonia Therapeutics Market Snippet by Region
• 2.2. Competitive Insights

3. Pneumonia Therapeutics Key Market Trends

• 3.1. Pneumonia Therapeutics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Pneumonia Therapeutics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Pneumonia Therapeutics Market Opportunities
• 3.4. Pneumonia Therapeutics Market Future Trends

4. Pneumonia Therapeutics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Pneumonia Therapeutics Market : Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Pneumonia Therapeutics Market Landscape

• 6.1. Pneumonia Therapeutics Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Pneumonia Therapeutics Market - By Product

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
  • 7.1.2. Drugs
  • 7.1.3. Oxygen Therapy
  • 7.1.4. Vaccine

8. Pneumonia Therapeutics Market - By Infection

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Infection, 2025 & 2033 (%)
  • 8.1.2. Hospital-acquired Pneumonia (HAP)
  • 8.1.3. Community-acquired Pneumonia (CAP)
  • 8.1.4. Ventilator-associated Pneumonia (VAP)

9. Pneumonia Therapeutics Market - By Route of Administration

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
  • 9.1.2. Oral
  • 9.1.3. Parenteral
  • 9.1.4. Others

10. Pneumonia Therapeutics Market - By End Use

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
  • 10.1.2. Hospitals
  • 10.1.3. Specialty Clinics
  • 10.1.4. Homecare
  • 10.1.5. Others

11. Pneumonia Therapeutics Market - By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Pneumonia Therapeutics Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Pneumonia Therapeutics Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.17. Denmark
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.17.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.17.4. Denmark Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.17.5. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.17.6. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.18. Rest of Europe
    • 11.3.18.1. Overview
    • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Pneumonia Therapeutics Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.16. Taiwan
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.16.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.16.4. Taiwan Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.16.5. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.16.6. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.17. Vietnam
    • 11.4.17.1. Overview
    • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.17.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.17.4. Vietnam Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.17.5. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.17.6. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.18. Rest of APAC
    • 11.4.18.1. Overview
    • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.18.4. Rest of APAC Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.4.18.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.18.6. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Pneumonia Therapeutics Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Pneumonia Therapeutics Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.14. Iran
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.14.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.14.4. Iran Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.6.14.5. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.14.6. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.15. Qatar
    • 11.6.15.1. Overview
    • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.15.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.15.4. Qatar Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.6.15.5. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.15.6. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.16. Rest of MEA
    • 11.6.16.1. Overview
    • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.16.4. Rest of MEA Market Size and Forecast, By Infection, 2020 - 2033 (US$ Million)
    • 11.6.16.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.16.6. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Pneumonia Therapeutics Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Pfizer Inc.
  • 12.2.2. Merck & Co., Inc.
  • 12.2.3. AstraZeneca PLC
  • 12.2.4. GlaxoSmithKline plc (GSK)
  • 12.2.5. Sanofi S.A.
  • 12.2.6. F. Hoffmann-La Roche Ltd.
  • 12.2.7. Novartis AG
  • 12.2.8. Eli Lilly and Company
  • 12.2.9. Teva Pharmaceutical Industries Ltd.
  • 12.2.10. Sun Pharmaceutical Industries Ltd.
  • 12.2.11. Lupin Limited
  • 12.2.12. Aurobindo Pharma Limited
  • 12.2.13. Baxter International Inc.
  • 12.2.14. Mylan N.V.
  • 12.2.15. Cipla Limited
  • 12.2.16. Abbott Laboratories
  • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us